title: Contractile protein phosphorylation predicts human heart disease phenotypes.
abstract: Human heart failure has been associated with a low level of thin-filament protein phosphorylation and an increase in calcium sensitivity of contraction relative to both "control" human heart tissue and tissue from small animal models. However, diverse strategies of human tissue procurement and the reliance on tissue obtained from subjects with end-stage heart failure suggest this may be an incomplete characterization. Therefore, we evaluated cardiac left ventricular (LV) biopsy samples from patients with aortic stenosis undergoing valve replacement who presented either with LV hypertrophy and preserved systolic function (Hyp) or with LV dilation and reduced ejection fraction (Dil). In Hyp, total troponin I (TnI) phosphorylation was markedly increased and myosin light chain 2 (MLC2) phosphorylation was unchanged relative to a control group of patients with normal LV function. Conversely, in Dil, total TnI phosphorylation was significantly reduced compared with control subjects and MLC2 phosphorylation was increased. Site-specific analysis of TnI phosphorylation revealed phenotype-specific differences such that Hyp samples demonstrated significant increases in phosphorylation at serine 22/23 and Dil samples had significant decreases at serine 43. The ratio of phosphorylation at the two sites was biased toward serine 22/23 in Hyp and toward serine 43/45 in Dil. Western blot analysis showed that protein phosphatase-1 was reduced in Hyp and protein phosphatase-2 was reduced in Dil. These data suggest that posttranslational modifications of sarcomeric proteins, both singly and in combination, are stage specific. Defining these changes in progressive heart disease may provide important diagnostic and treatment information.
authors.affiliation: Division of Cardiology, Department of Medicine, University of Colorado Denver, Aurora, CO 80045, USA. lori.walker@ucdenver.edu
authors.forename: Lori A
authors.initials: LA
authors.lastname: Walker
authors.forename: David A
authors.initials: DA
authors.lastname: Fullerton
authors.forename: Peter M
authors.initials: PM
authors.lastname: Buttrick
mesh_terms: D000368:Aged; D001024:Aortic Valve Stenosis / Q000378:metabolism* / Q000473:pathology; D001706:Biopsy; D024722:Cardiac Myosins / Q000378:metabolism*; D006332:Cardiomegaly / Q000378:metabolism* / Q000473:pathology; D016022:Case-Control Studies; D005260:Female; D015870:Gene Expression; D006352:Heart Ventricles / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D018994:Myosin Light Chains / Q000378:metabolism*; D010641:Phenotype; D010766:Phosphorylation; D054645:Protein Phosphatase 1 / Q000235:genetics / Q000378:metabolism; D054648:Protein Phosphatase 2 / Q000235:genetics / Q000378:metabolism; D012694:Serine / Q000378:metabolism; D019210:Troponin I / Q000378:metabolism*
chemical_list: D018994:Myosin Light Chains; D019210:Troponin I; C107184:myosin light chain 2; D012694:Serine; D054645:Protein Phosphatase 1; D054648:Protein Phosphatase 2; D024722:Cardiac Myosins
keywords: heart failure; hypertrophy; phosphorylation; signal transduction; stenosis
references.citation: J Mol Cell Cardiol. 1999 Apr;31(4):867-80
references.pmid: 10329214
references.citation: Science. 2000 Jan 21;287(5452):488-91
references.pmid: 10642551
references.citation: Mol Cell Biol. 2002 Jun;22(12):4124-35
references.pmid: 12024026
references.citation: Cardiovasc Res. 1998 Dec;40(3):440-3
references.pmid: 10070484
references.citation: Ann Biomed Eng. 2000 Aug;28(8):991-1001
references.pmid: 11144684
references.citation: J Mol Cell Cardiol. 2010 Jun;48(6):1180-6
references.pmid: 19799909
references.citation: Circulation. 2001 Feb 6;103(5):670-7
references.pmid: 11156878
references.citation: Cardiovasc Res. 2005 Oct 1;68(1):98-108
references.pmid: 15975567
references.citation: N Engl J Med. 1984 Sep 27;311(13):819-23
references.pmid: 6382011
references.citation: Cardiovasc Res. 2003 Jan;57(1):37-47
references.pmid: 12504812
references.citation: J Mol Cell Cardiol. 2009 Sep;47(3):365-71
references.pmid: 19481088
references.citation: Circ Res. 1991 Dec;69(6):1470-5
references.pmid: 1954671
references.citation: Cardiovasc Res. 2008 Mar 1;77(4):649-58
references.pmid: 18055579
references.citation: Am J Physiol Cell Physiol. 2009 Jan;296(1):C47-58
references.pmid: 18923061
references.citation: Hypertens Res. 2008 Apr;31(4):725-35
references.pmid: 18633185
references.citation: J Biol Chem. 2009 Feb 20;284(8):5097-106
references.pmid: 19106098
references.citation: J Mol Cell Cardiol. 2006 Apr;40(4):465-73
references.pmid: 16445938
references.citation: J Muscle Res Cell Motil. 2011 Mar;31(5-6):309-14
references.pmid: 21184256
references.citation: Circ Heart Fail. 2011 Jul;4(4):425-32
references.pmid: 21540356
references.citation: Physiol Rev. 1999 Jan;79(1):215-62
references.pmid: 9922372
references.citation: Circ Res. 2005 Nov 25;97(11):1156-63
references.pmid: 16224063
references.citation: Circ Res. 2000 Mar 3;86(4):386-90
references.pmid: 10700442
references.citation: Basic Res Cardiol. 1992;87 Suppl 1:129-41
references.pmid: 1386730
references.citation: Am J Physiol Heart Circ Physiol. 2001 Apr;280(4):H1814-20
references.pmid: 11247796
references.citation: Circ Res. 2004 Aug 20;95(4):424-32
references.pmid: 15242976
references.citation: Circulation. 2009 Mar 24;119(11):1473-83
references.pmid: 19273718
references.citation: Circ Res. 1980 Feb;46(2):292-300
references.pmid: 6444279
references.citation: Biochem Cell Biol. 2008 Feb;86(1):70-8
references.pmid: 18364747
references.citation: Am J Physiol Heart Circ Physiol. 2005 Oct;289(4):H1736-43
references.pmid: 15908465
references.citation: N Engl J Med. 2008 Mar 27;358(13):1370-80
references.pmid: 18367740
references.citation: J Mol Cell Cardiol. 2009 Apr;46(4):526-35
references.pmid: 19639678
references.citation: Microsc Res Tech. 2000 Sep 15;50(6):500-9
references.pmid: 10998639
references.citation: Cell. 2001 Nov 30;107(5):631-41
references.pmid: 11733062
references.citation: Curr Cardiol Rep. 2009 Nov;11(6):422-9
references.pmid: 19863866
references.citation: J Biol Chem. 2001 Jul 6;276(27):24519-24
references.pmid: 11346659
references.citation: Cardiovasc Res. 2004 Aug 1;63(2):245-55
references.pmid: 15249182
references.citation: Circ Res. 2009 Dec 4;105(12):1232-9
references.pmid: 19850940
references.citation: Circ Res. 1986 Sep;59(3):297-309
references.pmid: 2876788
references.citation: Circ Res. 2011 Oct 28;109(10):1176-94
references.pmid: 22034480
references.citation: J Biol Chem. 1999 Jul 23;274(30):21085-94
references.pmid: 10409661
references.citation: J Mol Cell Cardiol. 2007 Jan;42(1):247-59
references.pmid: 17081561
references.citation: Circ Res. 2005 Apr 15;96(7):756-66
references.pmid: 15746443
references.citation: Am J Physiol Regul Integr Comp Physiol. 2007 Sep;293(3):R963-73
references.pmid: 17609315
references.citation: Circ Res. 1995 May;76(5):720-5
references.pmid: 7728988
references.citation: Cardiovasc Res. 2006 Mar 1;69(4):876-87
references.pmid: 16376870